If you’ve rolled up your sleeve for a COVID-19 shot, you’ve probably wondered what’s happening inside your body afterward. Most people feel something — soreness, fatigue, a mild fever — but questions about duration, rarity of serious events, and what “long-term” actually means linger. Ireland’s health authorities have tracked this from the very first dose, and the data tells a clearer story than many online discussions suggest.

4 related posts

Most side effects: mild and short-lived · Common reactions: pain at injection site, headache, fatigue · Rare serious risks: blood clots, myocarditis · Duration of common effects: 1-3 days · Monitoring body: HPRA, HSE, global agencies

Quick snapshot

1Confirmed facts
  • Mild effects dominate: pain, fatigue, headache (HSE Ireland)
  • 21,471 suspected reports to HPRA as of January 2026 (HPRA)
  • Serious allergic reactions: roughly 1 in 100,000 (NOHC Ireland)
2What’s unclear
  • Effects beyond 2-3 years post-vaccination lack broad confirmation (PMC Study)
  • Causality for extremely rare events not fully established (PMC Study)
  • Long-term menstrual disruption data sparse (PMC Study)
3Timeline signal
  • Ireland’s programme began 29 December 2020 (Wikipedia)
  • Reports peaked at 17,871 in 2021, falling to 127 in 2025 (HPRA)
  • NIAC updated recommendations in May 2025 (HIQA)
4What’s next
  • EMA PRAC continues monitoring; HPRA feeds into EU-wide review (HPRA online form)
  • Booster uptake and updated formulations will generate fresh data (HPRA online form)
  • Report any unexpected effects via the HPRA online form
Aspect Detail
Primary vaccines monitored Pfizer, Moderna, others
Reporting bodies HPRA Ireland, HSE, global
Mild effects rate Very high, short duration
Serious events Rare, less than 0.01% per studies
Vaccination programme start 29 December 2020
Pfizer-BioNTech authorised 21 December 2020
AstraZeneca age restriction Over 60s only
Allergic reaction incidence 1 in 100,000
LTAEs reported prevalence 16% in studied group

How long do COVID shot side effects last?

For the vast majority of recipients, the answer is: not long. The Health Service Executive (HSE) reports that most COVID-19 vaccine side effects are mild to moderate and resolve within one to three days. This aligns with what vaccinators observe clinically — the immune system is responding, and that response naturally tapers off.

Side effect reports filed with the Health Products Regulatory Authority (HPRA) tell a broader story across time. The volume of suspected side effect reports peaked dramatically in 2021, when Ireland’s vaccination campaign was at full scale. According to HPRA data updated through 26 February 2026, reports totalled 17,871 that year. By 2025, that number had fallen to 127 — a drop of more than 99% from the peak.

Common side effects duration

  • Tenderness or swelling in the arm: typically resolves within 2-3 days
  • Fatigue and headache: most cases improve within 1-2 days
  • Fever (38°C or above) and chills: usually subside within 24-48 hours
  • Muscle and joint pain: commonly gone within 1-3 days

Factors affecting duration

Age plays a role. Younger recipients tend to report more intense reactions, particularly after the second mRNA dose. According to Irish Heart, which quoted HPRA data, side effects are more frequent and more intense after the second mRNA dose, especially in younger groups. This matches what clinical trials initially observed and what has been confirmed in real-world Irish data.

The upshot

Ireland’s pharmacovigilance data shows that reports have plummeted as the programme matured. By 2025, HPRA received just 127 suspected side effect reports — down from 17,871 in 2021. The overwhelming majority of people who get vaccinated experience nothing more than a brief, manageable discomfort.

Bottom line: The implication: side effect reporting has declined in lockstep with programme maturity, not because risks have changed but because the initial surge of immune responses to a novel vaccine has normalised.

What are the most common side effects?

HSE Ireland categorises side effects by frequency, and the picture is consistent across all approved vaccines. “Very common” effects — experienced by more than 1 in 10 people — include tenderness or swelling in the arm, feeling tired, headache, muscle pain, joint pain, diarrhoea, fever of 38°C or above, and chills.

“Common” effects (up to 1 in 10 people) add nausea, vomiting, and redness in the arm to the list. These are signs that the immune system is recognising the vaccine antigen and mounting a response — a normal, expected process that the body handles without intervention in almost every case.

Local reactions

Pain, redness, or swelling at the injection site represents the most frequently reported local reaction. HSE guidance notes that this typically appears within hours of vaccination and peaks around the first or second day before gradually subsiding. applying a cool, damp cloth and keeping the arm moving can ease discomfort.

Systemic symptoms

Beyond the arm, systemic symptoms — those affecting the whole body — are the next most frequently reported. Headache and fatigue lead the list, followed by muscle aches and mild fever. These tend to emerge slightly later than local reactions, often appearing the evening after vaccination or the following morning.

Why this matters

The frequency hierarchy matters because it sets expectations. People who know that a sore arm and mild fatigue are “very common” are less likely to interpret these symptoms as alarming. HPRA received 21,471 suspected side effect reports total through January 2026, but the vast majority of vaccine doses administered in Ireland number in the millions — putting the reported-effect rate at a small fraction of total doses.

Bottom line: The pattern: the most reported effects are also the most benign, and the sheer volume of doses administered means even mild reactions affect a large absolute number — but rarely represent any danger.

What are the risks of the COVID vaccine?

This is where honest, calibrated conversation matters most. The risks are real but rare, and they must be weighed against the established risks of COVID-19 disease itself — a point emphasised by Ireland’s National Immunisation Advisory Committee (NIAC) and echoed across global health bodies.

Serious allergic reactions illustrate the scale. According to NOHC Ireland data, serious allergic reactions occur in approximately 1 in 100,000 vaccinations. Every vaccinator in Ireland is trained to treat anaphylaxis immediately, and vaccination centres maintain adrenaline on hand. Despite this, documented cases remain extraordinarily uncommon.

Mild vs serious risks

The dividing line is clear in the data. Mild risks — soreness, fatigue, headache — affect tens of thousands of people and resolve without treatment. Serious risks affect a tiny fraction. HPRA’s breakdown by vaccine type shows that mRNA vaccines (Comirnaty, Spikevax) generated 14,295 reports, while adenoviral vaccines (Vaxzevria, Jcovden) generated 6,803 reports. Neither total is alarming when set against millions of doses.

Risk vs COVID disease

Health authorities consistently frame the risk calculus this way: the risks of vaccination must be weighed against the risks of getting COVID-19. Long-term COVID symptoms — fatigue, memory issues, difficulty concentrating — are more likely with age, higher BMI, and female sex, according to HIQA guidelines. These risks of the disease itself substantially outweigh the rare risks documented from vaccination.

What to watch

Symptoms of myocarditis and pericarditis — breathlessness, palpitations, chest pain — require urgent medical attention. In children, irritability, vomiting, difficulty feeding, and rapid breathing signal the same concern. HSE lists these symptoms clearly on its vaccination pages, and any recipient experiencing them should seek care immediately.

The catch: the risk-benefit calculation consistently favours vaccination, but only if rare adverse events are treated as medical urgencies rather than dismissed.

What are the long term side effects of the COVID vaccine?

The honest answer is that confirmed, widespread long-term side effects from COVID-19 vaccination have not emerged. Ireland’s pharmacovigilance system, coordinated through HPRA and the European Medicines Agency’s PRAC committee, continues active monitoring, but no pattern of persistent, widespread harm has been identified through several years of real-world data.

A study of physicians and dentists published on PMC found that 16% reported long-term adverse events (LTAEs), with fatigue, menstrual disturbances, myalgia, arthralgia, dizziness, and headache as primary symptoms. The study noted that no significant association was found between LTAEs and age, gender, or medical history, and that fatigue-related symptoms were most associated with Sinopharm vaccine — not the mRNA vaccines used widely in Ireland.

Reported long-term events

The PMC study, which carries medium confidence given its observational design and self-reported data, found that less than 20% of recipients may complain of symptoms that persist beyond the acute phase. These were mostly fatigue-related. The researchers noted that psychological and media factors may influence reporting rates — a methodological consideration that applies to all passive surveillance data.

Ongoing monitoring

EMA PRAC continuously monitors COVID-19 vaccine safety, and HPRA participates in this European-wide review. NIAC updated its COVID-19 vaccine recommendations in May 2025, covering pregnant women, infants, and healthcare workers. Any emerging safety signal would trigger formal review. As of the most recent HPRA data update (26 February 2026), no such signal had altered the overall positive safety profile of the vaccines used in Ireland.

Bottom line: No widespread long-term harm has been confirmed through Ireland’s pharmacovigilance system or peer-reviewed studies. Pfizer-BioNTech showed the lowest association with long-term adverse events among the vaccines studied. For most people: mild, transient effects are the norm, and serious long-term events remain exceptionally rare.

The implication: ongoing monitoring by HPRA and EMA PRAC means any emerging long-term pattern would trigger formal review, but as of early 2026 the data remain reassuring.

What are the most serious side effects of COVID vaccines?

When health authorities classify events as serious, they mean side effects that require hospitalisation, cause persistent disability, or are life-threatening. In Ireland’s monitoring data, these represent a tiny fraction of total reports — but they deserve specific attention because they are the reason pharmacovigilance exists.

Two categories have received the most scrutiny: blood clots associated with adenovirus-based vaccines, and heart inflammation (myocarditis or pericarditis) associated primarily with mRNA vaccines. Both are rare, and both have been studied extensively since early 2021.

Blood clots and bleeding

AstraZeneca’s Vaxzevria vaccine was restricted to people over 60 in Ireland due to safety data, following a pattern observed across Europe. The mechanism has been studied — Science.org reported on research explaining why adenovirus-based shots caused life-threatening blood clots in rare cases. For most people, however, no increased clotting risk exists, and the absolute risk remains extremely low for those outside the identified higher-risk groups.

Heart inflammation

Myocarditis and pericarditis appear most frequently in younger males after the second mRNA dose. HSE guidance lists symptoms — breathlessness, palpitations, chest pain — and instructs anyone experiencing these to seek urgent medical help. The condition is rare: studies suggest it occurs in a small number per million doses, well below 1%, and most cases resolve with rest and standard treatment.

Upsides

  • Mild effects are expected and self-resolving for most recipients
  • Serious events are genuinely rare (<0.01% of doses)
  • Vaccination risks are substantially lower than COVID-19 disease risks
  • Ireland’s monitoring system is robust and transparent
  • Report any unexpected effects directly to HPRA

Downsides

  • Some people experience more intense effects after the second dose
  • Very rare serious events (myocarditis, clots) do occur
  • Long-term data beyond 2-3 years remains limited
  • Media attention has inflated perception of risk for some readers
  • Booster effects may differ from primary series

What this means: the rarest serious events have received the most regulatory attention, and targeted restrictions — such as AstraZeneca’s age limit — reflect evidence-based responses rather than vaccine hesitancy.

HSE Ireland — Most COVID-19 vaccine side effects are mild and do not last long.

HPRA (via Irish Heart) — The number of reports of facial paralysis received so far is in line with the expected rate at which these conditions occur naturally.

PMC Study Authors — Less than 20% of COVID-19 vaccine recipients may complain of long-term adverse events that are mostly fatigue-related.

The pattern across Ireland’s monitoring data is unambiguous: the vast majority of people who receive COVID-19 vaccines experience mild, transient effects that resolve within days. The pharmacovigilance system — led by HPRA in Ireland and coordinated through EMA PRAC at the European level — has identified rare serious events and acted on them, whether through restrictions on specific vaccines or public guidance on symptoms to watch for.

For patients and healthcare workers weighing vaccination decisions, the trade-off is clear: the documented risks of COVID-19 disease itself — including long-term symptoms affecting multiple organ systems — substantially outweigh the rare risks identified through years of monitoring. Reporting unexpected effects directly to HPRA contributes to the ongoing safety picture that keeps Ireland’s vaccination programme reliable.

Related reading: Can Cats Get COVID?

Additional sources

irishheart.ie, www2.hse.ie, hpsc.ie, hiqa.ie, carlowlive.ie, ibm.com

Official data from HSE and HPRA aligns with global trends where mild symptoms prevail, as this detailed breakdown of rare risks highlights alongside long-term insights.

Don't miss these

Frequently asked questions

When do COVID vaccine side effects start?

Most side effects begin within hours of vaccination. Local reactions — pain and swelling at the injection site — often appear within the first few hours. Systemic symptoms like fatigue, headache, and mild fever typically emerge later, sometimes the evening of vaccination or the following morning. The timing reflects normal immune activation.

Do you feel ill after the latest COVID booster?

Many people report similar effects to their earlier doses, though individual responses vary. The booster is designed to refresh immunity, and the immune response it triggers can produce the same mild symptoms: arm soreness, fatigue, headache. Younger recipients and those receiving mRNA boosters may notice more pronounced effects after the second or booster dose, consistent with trial data.

Does the COVID vaccine cause chronic health problems?

Widespread chronic health problems caused by COVID-19 vaccination have not been confirmed through Ireland’s pharmacovigilance monitoring or large peer-reviewed studies. A small percentage of recipients report long-term symptoms — primarily fatigue-related — but no causal mechanism has been established, and reporting rates may be influenced by psychological and media factors. Most persistent symptoms resolve with time.

What are the worst effects of the Pfizer vaccine?

Pfizer-BioNTech (Comirnaty) has shown the lowest association with long-term adverse events among the vaccines studied. Rare serious effects include myocarditis, which occurs at very low rates and most commonly in younger males after the second dose. Severe allergic reactions are extremely rare — approximately 1 in 100,000 — and are treatable on-site. Overall, the safety profile of Comirnaty remains strongly positive.

What diseases have been linked to the COVID vaccine?

Rare links have been documented to myocarditis and pericarditis (particularly with mRNA vaccines) and to thrombosis with thrombocytopenia syndrome (primarily with adenovirus-based vaccines like AstraZeneca’s Vaxzevria). These events are exceptionally rare — far below 1% of doses — and health authorities have taken regulatory action where the risk-benefit balance shifted for specific groups.

How long will COVID vaccine side effects last?

For most recipients, 1-3 days. Pain at the injection site, fatigue, headache, and mild fever typically peak within the first 48 hours and resolve fully within three days. A small number of people experience effects that linger slightly longer, but severe or persistent symptoms warrant contact with a healthcare provider. Heavy menstrual bleeding, when it occurs, is usually not serious and short-lived per HSE guidance.

What are the long term effects of the coronavirus vaccine?

Confirmed long-term effects remain rare. Ireland’s HPRA and the European medicines safety network continue active monitoring, and the data through early 2026 shows no emergence of widespread persistent harm. The PMC study found that less than 20% of recipients reported long-term symptoms, mostly fatigue-related, with no clear link to age, gender, or medical history. For most people, vaccination produces no lasting effects beyond short-term immune activation.

For anyone in Ireland still weighing a vaccination decision, the evidence is clear: mild, transient effects are the overwhelming norm, serious events are genuinely rare, and the risks of unvaccinated COVID-19 infection substantially exceed the documented risks of the vaccines used to prevent it.